Clinical Trial

Safety and Pharmacokinetics of Vasopressin

Study Description

Safety and Pharmacokinetics of Vasopressin in Healthy Volunteers

Open-label Phase I pharmacokinetic (PK) study of VasostrictAR (vasopressin injection, USP) in healthy volunteers.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Vasostrict Injectable Product

Vasostrict® (vasopressin injection, USP)

Additional Information

Official Study Title

A Phase 1, Open-Label, Two-Arm, Parallel-Group, Pharmacokinetic Study on Plasma Clearance of Vasopressin in Healthy Volunteers

Clinical Trial ID

NCT04093050

ParticipAid ID

bo2z3a